Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphomul vs Liposomal Amphotericin B in Visceral Leishmaniasis
NCT00876824Phase 3Completed
- Sponsor
- Bharat Serums and Vaccines
- Start
- Jul 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amphotericin b in visceral leishmaniasis (VL), sponsored by Bharat Serums and Vaccines. Started Jul 2009; status: completed.
02
Drugs
amphotericin b
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on NCT00876824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00876824.